Zhengxiang Han Selected Research

Zhengxiang Han Research Topics

Disease

10	Neoplasms (Cancer) 03/2024 - 11/2016
7	Breast Neoplasms (Breast Cancer) 11/2023 - 07/2015
5	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2022
2	Hemorrhage 12/2023 - 01/2022
2	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2023 - 01/2023
2	Inflammation (Inflammations) 01/2021 - 10/2020
1	Triple Negative Breast Neoplasms 03/2024
1	Hypertension (High Blood Pressure) 12/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023
1	Disease Progression 12/2023
1	Stomatitis 12/2023
1	Proteinuria 12/2023
1	Fatigue 12/2023
1	Hemoptysis 12/2023
1	Ankylosing Spondylitis 11/2023
1	Microsatellite Instability 08/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Adenocarcinoma 06/2022
1	Stomach Neoplasms (Stomach Cancer) 06/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Deglutition Disorders (Dysphagia) 01/2022
1	Pain (Aches) 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Amnesia (Dissociative Amnesia) 10/2020
1	Mental Disorders (Mental Disorder) 10/2020
1	Anhedonia 10/2020
1	Dizziness (Lightheadedness) 10/2020
1	Pneumoconiosis 05/2017
1	Vomiting 11/2016
1	Infections 07/2015
1	Encephalomyelitis (Myeloencephalitis) 12/2012

Drug/Important Bio-Agent (IBA)

5	Neuropilin-1IBA 03/2024 - 01/2017
4	camrelizumabIBA 04/2023 - 01/2022
3	apatinibIBA 03/2024 - 06/2022
2	pyrotinibIBA 11/2023 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 08/2023 - 07/2015
2	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2023
2	Capecitabine (Xeloda)FDA Link 06/2022 - 01/2021
2	Small Interfering RNA (siRNA)IBA 01/2022 - 07/2015
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 10/2020
2	CytokinesIBA 01/2021 - 12/2012
2	Kai-Xin-SanIBA 01/2021 - 10/2020
2	Messenger RNA (mRNA)IBA 06/2019 - 07/2015
1	Immune Checkpoint InhibitorsIBA 03/2024
1	anlotinibIBA 12/2023
1	CreatinineIBA 12/2023
1	Etoposide (VP 16)FDA LinkGeneric 12/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2023
1	Indicators and Reagents (Reagents)IBA 08/2023
1	lenvatinibIBA 01/2023
1	TegafurIBA 06/2022
1	Docetaxel (Taxotere)FDA Link 06/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2022
1	Long Noncoding RNAIBA 02/2022
1	Chaperonin Containing TCP-1IBA 01/2022
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021
1	PlatinumIBA 01/2021
1	ElementsIBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	rucaparibIBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	niraparibIBA 01/2021
1	olaparibIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 10/2019
1	Phosphotransferases (Kinase)IBA 10/2019
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 10/2019
1	3' Untranslated Regions (3' UTR)IBA 06/2019
1	RNA (Ribonucleic Acid)IBA 06/2019
1	LuciferasesIBA 06/2019
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 06/2019
1	HydrogenIBA 05/2017
1	Protons (Proton)IBA 05/2017
1	CateninsIBA 01/2017
1	NeuropilinsIBA 01/2017
1	AgarIBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Thalidomide (Thalomid)FDA Link 11/2016

Therapy/Procedure

7	Therapeutics 03/2024 - 01/2021
7	Drug Therapy (Chemotherapy) 12/2023 - 11/2016
1	Immunotherapy 01/2023
1	Radiotherapy 01/2022
1	Adjuvant Chemotherapy 01/2022
1	Chemoradiotherapy 01/2022
1	Stents 01/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021